Answer
Oct 31, 2024 - 01:03 PM
Fluticasone furoate vilanterol, marketed under the brand name Breo Ellipta, is used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It combines a corticosteroid (fluticasone furoate) to reduce inflammation and a long-acting beta agonist (vilanterol) to relax the muscles around the airways, making it easier to breathe.